These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 18342966)
1. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Salas S; Deville JL; Giorgi R; Pignon T; Bagarry D; Barrau K; Zanaret M; Giovanni A; Bourgeois A; Favre R; Duffaud F Radiother Oncol; 2008 May; 87(2):195-200. PubMed ID: 18342966 [TBL] [Abstract][Full Text] [Related]
2. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Nishimura G; Nagao J Auris Nasus Larynx; 2009 Apr; 36(2):199-204. PubMed ID: 18632233 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584 [TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer. Rivera F; Eugenia Vega-Villegas M; López C; Francisca López-Brea M; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Hinojo C; Márquez R; Angel Alonso-Bermejo M; Salcedo M; Blanco Y; Vega N; López-Tarruella S; Sanz-Ortiz J Acta Oncol; 2008; 47(8):1584-9. PubMed ID: 18607841 [TBL] [Abstract][Full Text] [Related]
5. [Concomitant radiotherapy-chemotherapy for unresectable cancers of the head and neck: a retrospective analysis of 130 patients]. Resche-Rigon P; Pignon T; Giovanni A; Gras R; Bagarry D; Zanaret M Ann Otolaryngol Chir Cervicofac; 2003 Feb; 120(1):3-13. PubMed ID: 12717312 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy. Dietl B; Marienhagen J; Schäfer C; Kölbl O Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation. Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S J BUON; 2008; 13(3):369-76. PubMed ID: 18979552 [TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series. Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M Oncology; 2009; 76(6):405-12. PubMed ID: 19407473 [TBL] [Abstract][Full Text] [Related]
9. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P; Lee CC; Chen LF Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma. Preuss SF; Klussmann JP; Wittekindt C; Damm M; Semrau R; Drebber U; Guntinas-Lichius O Eur J Surg Oncol; 2007 Apr; 33(3):358-63. PubMed ID: 17157472 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers. Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615 [TBL] [Abstract][Full Text] [Related]
12. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Di Fiore F; Lecleire S; Pop D; Rigal O; Hamidou H; Paillot B; Ducrotté P; Lerebours E; Michel P Am J Gastroenterol; 2007 Nov; 102(11):2557-63. PubMed ID: 17680847 [TBL] [Abstract][Full Text] [Related]
13. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ishizuka M; Nagata H; Takagi K; Kubota K Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907 [TBL] [Abstract][Full Text] [Related]
14. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer. Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080 [TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231 [TBL] [Abstract][Full Text] [Related]
17. [The prognostic value of time parameters in adjuvant radiotherapy of head and neck cancer. A retrospective analysis of 138 patients]. Dietl B; Schäfer C; Kölbl O Strahlenther Onkol; 2005 Dec; 181(12):800-7; discussion 808-9. PubMed ID: 16362791 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Read JA; Choy ST; Beale PJ; Clarke SJ Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244 [TBL] [Abstract][Full Text] [Related]
19. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193 [TBL] [Abstract][Full Text] [Related]
20. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]